27
10
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T6928 | Pantoprazole | SKF96022,BY1023 | Apoptosis , Proton pump , Autophagy |
Pantoprazole (BY1023) is a proton pump inhibitor used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. | |||
T0161 | Pantoprazole Sodium Hydrate | SKF96022 sodium hydrate,BY1023 (sodium hydrate),SKF96022 (sodium hydrate) | Apoptosis , Potassium Channel , Proton pump , Autophagy |
Pantoprazole Sodium Hydrate (BY1023 (sodium hydrate)) is a proton pump inhibitor drug, used for short-term treatment of erosion and ulceration of the esophagus caused by gastroesophageal reflux disease. | |||
T6929 | Pantoprazole sodium | Pantecta,SKF96022 sodium,SKF96022 (sodium),BY1023 (sodium),BY-1023 sodium,Pantoloc | Apoptosis , Others , Proton pump , HIF , Autophagy |
Pantoprazole sodium (Pantecta) is the sodium salt form of a substituted benzimidazole with proton pump inhibitor activity. Pantoprazole sodium is a lipophilic, weak base that crosses the parietal cell membrane and enters... | |||
T4510 | Polaprezinc | Zinc L-carnosine | Others |
Polaprezinc is an bioavailable chelate comprised of zinc and L-carnosine, known for its gastrointestinal protective properties, as well as its anti-ulcer, antioxidant, and anti-inflammatory effects. | |||
T12215 | Nexopamil racemate | (Rac)-Nexopamil | Calcium Channel , 5-HT Receptor |
Nexopamil racemate((Rac)-Nexopamil) is a racemate of Nexopamil. The Nexopamil racemate has potential anti-asthmatic and anti-ulcer activity. | |||
T5008 | Teprenone | Tetraprenylacetone,Geranylgeranylacetone | HSP |
Teprenone (Geranylgeranylacetone) is a anti-ulcer drug, and works as an inducer of heat shock proteins (HSPs). | |||
T77618 | COX-2-IN-34 | COX | |
COX-2-IN-34 is a selective, orally potent COX-2 inhibitor that shows anti-inflammatory activity without gastric ulcer toxicity during experiments in mice. | |||
T10872L | CP 96021 | 5-HT Receptor | |
CP 96021 is a group of 5-HT1 receptors and 5-HT2 receptors antagonists that have anti-inflammatory properties and are non-non-self anti-ulcer compounds for the treatment of gastrointestinal tract and respiratory asthma. | |||
T6548 | Irsogladine | Dicloguamine | PDE , AChR |
Irsogladine (Dicloguamine) is an anti-gastric ulcer agent that facilitates gap-junctional intercellular communication through M1 muscarininc acetylcholine receptor binding. | |||
T6710 | Troxipide | Aplace | Others |
Troxipide (Aplace), a new-type systemic non-antisecretory gastric cytoprotective agent, which is mucus-secreting, anti-ulcer, and anti-inflammatory properties irrespective of pH of stomach or duodenum. | |||
T77617 | MMP-9-IN-6 | MMP | |
MMP-9-IN-6 is an MMP-9 inhibitor with an IC50 value of 50 μM and good anti-ulcer efficacy.MMP-9-IN-6 has potential anti-tumor activity and can be used to study tissue remodeling, wound repair and atherosclerosis. | |||
T16865 | SCH28080 | ATPase , Proton pump | |
SCH28080 is a reversible and K+-competitive inhibitor of gastric H+/K+-ATPase with an IC50 value of 20 nM (rabbit microsomal membrane).SCH28080 is a potent inhibitor of acid secretion in vivo with anti-ulcer activity, an... | |||
T1639 | Amlexanox | CHX3673,Amoxanox,AA673 | IL Receptor , FGFR , Others , IκB/IKK |
Amlexanox (AA673) is an anti-aphthous ulcer drug. Amlexanox inhibits the synthesis and release of inflammatory mediators, including leukotrienes and histamine, from mast cells, neutrophils, and mononuclear cells. Amlexan... | |||
T1562 | Rebamipide | Proamipide,OPC12759 | Free radical scavengers , COX , Prostaglandin Receptor |
Rebamipide (OPC12759) is a quinolinone derivative with anti-ulcer and anti-inflammatory activities. Rebamipide induces cyclooxygenase 2 (COX2) synthesis which results in an increase in endogenous prostaglandin synthesis ... | |||
T19763 | Cetraxate hydrochloride | DV-1006,DV 1006,Cetraxate HCl,DV1006 | Serine/threonin kinase |
Cetraxate hydrochloride (DV10062) is an oral gastrointestinal medication. It has a cytoprotective effect. | |||
T10008 | BTM-1086 | Others | |
BTM-1086 is a potent gastric secretory inhibitor and an anti-ulcer agent. | |||
T24821 | Spizofurone | Espizofurona | |
Spizofurone is a new anti-ulcer agent. | |||
T28613 | RP73870 | RP 73870,RP-73870 | |
RP73870 is a gastrin/cholecystokinin-B receptor antagonist and H2 receptor antagonist with potent anti-ulcer activity. | |||
T24728 | Rosaprostol | C 83 | |
Rosaprostol is an agent of the anti-ulcer drug. | |||
T24254 | KB-5492 anhydrous | KB-5492,KB5492,KB 5492 | |
KB 5492 is an agent of anti-ulcer. It preventing cysteamine-induced duodenal ulcers by stimulating duodenal HCO3- secretion. | |||
T69801 | AU-461 | ||
AU-461 is a gastric H(+)/K(+) ATPase inhibitor which acts as an anti-ulcer agent. | |||
T0157L | Roxatidine acetate | ||
Roxatidine acetate is an anti-ulcer agent and histamine antagonist that inhibits gastric acid secretion. Compared to other similar drugs, Roxatidine acetate has an improved safety profile, in part because lower doses of ... | |||
T69805 | AU-006 | ||
AU-006 is an anti-ulcer drug which is effective in the treatment of gastric ulcers by inhibiting gastric acid secretion. | |||
T68200 | Roxatidine hydrochloride | ||
Roxatidine hydrochloride is an anti-ulcer agent and histamine antagonist that suppresses gastric acid secretion. It effectively heals duodenal and gastric ulcers and reduces ulcer pain. Roxatidine acetate has an improved... | |||
T81074 | Sucrose octasulfate sodium | ||
Sucrose octasulfate, a constituent of sulfoaluminum, promotes the release of somatostatin-like immunoreactivity (SLI) through direct interaction with D cells within the gastric mucosa, thereby exerting its ulcer-healing ... | |||
T74118 | Roxatidine | ||
Roxatidine is an active metabolite of Roxatidine acetate hydrochloride, is a histamine H2-receptor antagonist. Roxatidine, an anti-ulcer agent, suppresses histamine release (thus inhibiting proton secretion) and inhibits... | |||
T62396 | KB-5492 free base | ||
KB-5492 free base is a potent and selective sigma receptor inhibitor, inhibiting [3H]1,3-di(2-tolyl)guanidine (DTG) binding to the sigma receptor with an IC50 value of 3.15 μM. KB-5492 free base is an anti-ulcer agent. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T2833 | Dehydrocostus Lactone | Epiligulyl oxide,(-)-Dehydrocostus lactone | IκB/IKK |
Dehydrocostus Lactone ((-)-Dehydrocostus lactone) shows anti-inflammatory, anti-ulcer, immunomodulatory and anti-tumor properties. | |||
TN1568 | Deoxyartemisinin | 2-deoxyartemisinin | Antifection |
Deoxyartemisinin (2-deoxyartemisinin), a compound derived from Artemisia annua, has anti-inflammatory and anti-ulcer effects and is used in the study of malaria. | |||
TN2233 | Spathulenol | Antioxidant , Antifungal | |
Spathulenol is a small molecule compound from Aristolochia yunnanensis that has anti-inflammatory, antioxidant, anti-proliferation, anti-ulcer and anti-mycobacterium activities. Spathulenol showed significant antioxidant... | |||
TN6577 | Bletilloside A | 3-Methoxyshancigusin I | Others |
Bletilloside A(3-Methoxyshancigusin I) is a novel glucoside isolated from tubers of striped alfalfa with anti-gastric ulcer activity. | |||
T12681 | (±)-Vasicine | (±)-Peganine | Others |
(±)-Vasicine is the racemate of Vasicine. Vasicine isolated from Peganum harmala seeds, with anti-ulcer activity. | |||
TN1893 | Luteolin-3',7-di-O-glucoside | Others | |
Luteolin-3',7-di-O-glucoside has anti-ulcer and antioxidant activities. | |||
TN1302 | 6,8-Diprenylorobol | Others , HIV Protease , Antifection | |
6,8-Diprenylorobol possesses weaker anti-H. pylori activity, it may be a useful chemopreventive agent for peptic ulcer or gastric cancer in H. pylori-infected individuals. | |||
TN3926 | Eicosanyl caffeate | Others | |
Eicosanyl caffeate has anti-ulcer and moderate antioxidant properties, it exhibits potent elastase inhibitory activity, with the IC(50) value of 0.99 microg/mL. | |||
TN3852 | Dihydrolicoisoflavone | Antifection | |
Dihydrolicoisoflavone A possesses weaker anti-H. pylori activity, it may be useful chemopreventive agents for peptic ulcer or gastric cancer in H. pylori-infected individuals. | |||
TN1913 | Marmin | Calcium Channel , Antifection , Histamine Receptor | |
Marmin have anti-ulcer effects, which are ascribed primarily to the maintenance of the mucosal barrier integrity and inhibition of gastric motor activity and secondarily due to the prevention of the effects of endogenous... |